Company intelligence / Profile preview

Pharmaron

Ownership: Public · 300759.SZ
Employees: ~21000
Development stage: Commercial

Overview

Pharmaron does not have its own clinical pipeline but has an excellent track record in delivering R&D solutions to partners globally. It integrates advanced platforms such as chemical proteomics and gene editing to accelerate customer drug discovery. The company’s business segments include laboratory services (chemistry/bioscience), CMC/small molecule CDMO services, clinical development services (Phase I-IV), biologics & CGT services.

Therapeutic areas: Other
Modalities: Small moleculeBiologicCell and gene therapy productsOligonucleotidePeptideAntibodyAntibody-drug conjugate
Industry: Drug Discovery Services

Partnerships

Numerous partnerships with global pharmaceutical and biotechnology companies; specific names typically confidential or project-based.

Beyond the preview

Go deeper on Pharmaron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmaron.

Explore the full profile